Mitochondrial biogenesis and apoptosis as underlying mechanisms involved in the cardioprotective effects of Gallic acid against D-galactose-induced aging.

BACKGROUND: Aging is a main risk factor for the development of cardiovascular diseases (CVDs). Gallic acid (GA) is a phenolic compound derived from a wide range of fruits. GA has a wide spectrum of pharmacological properties, including anti-oxidative, anti-inflammatory, and cardioprotective effects. This research was conducted to determine the cardioprotective effect of GA on cardiac hypertrophy in aged rats. METHODS AND RESULTS: Following histological evaluation and through observing the heart, we found that GA improved the cardiac hypertrophy induced by D-galactose (D-GAL) in cardiac cells. To clarify the causes for this anti-aging effect, we evaluated the malonic dialdehyde levels and antioxidant enzyme activity in rat cardiac tissue. The levels of lactate dehydrogenase (LDH) and creatine kinase (CK-MB) in serum were measured. The levels of genes related to mitochondrial biogenesis, mitophagy, and apoptosis in cardiac tissue were surveyed. The findings represented that GA ameliorated antioxidant enzyme activity while significantly decreasing the malonic dialdehyde levels. Real-time PCR analysis proposed that GA effectively improved mitochondrial biogenesis in the heart via regulating the expression levels of Sirtuin 1 (SIRT1), PPARγ coactivator 1α (PGC1-α), nuclear factor erythroid 2-related factor 2 (Nrf2), and mitochondrial transcription factor A (TFAM). GA also mitigated apoptosis in the heart by modulating the expression levels of B-cell lymphoma protein 2 (Bcl-2) and Bcl-2-associated X (Bax). In addition, GA improved serum LDH and CK-MB levels. CONCLUSIONS: GA may alleviate aging-induced cardiac hypertrophy via anti-oxidative, mitoprotective, and anti-apoptotic mechanisms.

The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta, and prostaglandin E2 levels in periapical fluid: a double-blind randomized clinical trial.

BACKGROUND: The role of pro-resolving mediators in inflammation is a new concern in research. The effect of low-dose aspirin on production of a special kind of these mediators named aspirin triggered lipoxin (ATL) has been studied on different tissues. This randomized clinical trial evaluated the effect of low-dose aspirin on ATL and pro-inflammatory mediators' level in periapical fluid of necrotic teeth with large lesions. METHODS: Twenty-four patients with necrotic pulp and periapical lesion were randomly assigned to low-dose aspirin and placebo groups. In the first appointment, canals were shaped up to F3 size and #40 K-file and cleaned with 10 milliliters 2.5% sodium hypochlorite and 17% Ethylenediaminetetraacetic acid. Periapical fluid was sampled by a paper cone. The tooth was temporized without any intracanal medication. Tablets were administered for 7 days, then the teeth were re-opened and the sampling were repeated. Interleukin-1 beta (IL-1ß), prostaglandin E2 (PGE2) and ATL were analyzed by enzyme-linked immunosorbent assay. Data were analyzed with paired t-test using SPSS statistical software, version 21 (α = 0.05). RESULTS: A significant reduction in PGE2 and IL-1ß was noted in the aspirin-treated group while an increase in ATL was observed (P < 0.001). There was no significant difference in the mediator scores before and after in the placebo-treated group (P > 0.05). CONCLUSION: Low-dose aspirin can influence the inflammatory process by reducing pro-inflammatory mediators such as PGE2 and IL-1ß, as well as increasing the pro-resolving mediators such as ATL. TRIAL REGISTRATION: IRCT20191211045702N1.

A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.

Cross-talk among inflammation and colorectal cancer cells is chiefly reported through a complex of cytokines, chemokines, and growth factors. MicroRNA performs strategic roles in controlling a variety of signaling cascades. miR-34a is known as a master regulator of tumor suppression. Combined application of different miRNA-based agents and chemotherapeutic drugs has been used to augment drug sensitivity and may reinforce the antitumor effect. A lot of studies specify a substantial increase in the effectiveness of combination therapies. The anti-inflammatory activity of Zerumbone (ZER) was investigated in many cancers. In this study the level of the inflammatory cytokines including CXCL-12 (SDF-1), CCL-2 (MCP-1), TGF-ß and IL-33 has been measured in pmiR-34a-5p transfected and pmiR-34a-5p +ZER treated CRC cell lines (HCT-116 and SW48) by QRT-PCR and ELISA methods, respectively. The results showed that miR-34a could significantly inhibit cytokine expression in both cell lines for 48 and 72 h except SDF-1 which no inhibition was observed in SW48 cells. ZER suppressed SDF-1 for all three time points in both cell lines, while in SW48 cells IL-33 and TGF-ß were inhibited in 72 h and in HCT-116 cells MCP-1 diminished for only 24 h and TGF-ß diminished for all three times. Combination of both miR-34a and ZER suppressed TGF-ß, SDF-1 and MCP-1 in HCT-116 cells in all time points while in SW48 cells, suppression of most cytokines was observed in 48 and 72 h. Furthermore Colony formation assay and scratch test were employed to detect changes of proliferation and migration in CRC transfected and treated cells. Generally, we found that miR-34a could considerably decrease the expression of inflammatory cytokines and the combination of ZER+ miR-34 boosted this effect. Moreover the migration and proliferation decreased in treated and transfected cells and this reduction was more severe in miR-34a +ZER treatment. It is important to note that in the case of cell resistance to each of these therapeutic agents, inhibition of cytokines can be compensated by another one.

Association of interleukin-17 gene polymorphisms and susceptibility to brucellosis in Hamadan, western Iran.

IL-17is one of the most important inflammatory cytokines that stimulate immunity responses in humans infected with Brucella species, acting as a regulator that reduces release of γ-IFN, thus increasing resistance to brucellosis. Gene polymorphisms in the regulatory regions of cytokine-encoding genes affect the amountsof cytokines produced and play a fundamental role in infectious diseases. The aim of this study was to determine the association between IL-17 gene polymorphisms and susceptibility to brucellosis. In this case-control study, 86 patients with brucellosis and 86 healthy persons in Hamadan, western Iran, from September 2014 to September 2016, were included. IL-17 genetic variants at positions rs4711998 A/G, rs8193036 C/T, rs3819024 A/G, rs2275913 A/G, rs3819025 A/G, rs8193038 A/G, rs3804513 A/T, rs1974226 A/G and rs3748067 A/G were analyzed by restriction fragment length polymorphism-PCR. Serum IL-17 titers were measured by sandwich ELISA. GG genotypes at positions rs4711998 and rs3748067 were present significantly more frequently in patients with brucellosis than in controls (P < 0.05). The AA genotype at positions rs4711998, rs2275913 and rs3748067 and GG genotype at position rs19744226 were present significantly more frequently in controls than in the patient group. These results suggest that the AA genotype at positions rs3748067, rs3819025 and rs4711998 and GG genotype at position rs3819024 are likely protective factors against brucellosis, whereas the GG genotype at positions rs3748067, rs3819025 and rs4711998 and AA genotype at position rs3819024 may be risk factors against the disease. No significant relationships were found between serum IL-17 titers and genotypes of the single-nucleotide polymorphisms.

Effects of sitagliptin and vitamin D3 on T helper cell transcription factors and cytokine production in clinical subgroups of type 2 diabetes mellitus: highlights upregulation of FOXP3 and IL-37.

Objective: Gene expression level of T helper cell transcription factors and cytokines production in type-2 diabetes mellitus (T2DM) patients treated with mono- or combined sitagliptin and vitamin D3 (VitD3) were evaluated. Methods: Fifty-four nephropathic and 57 non-nephropathic T2DM patients were divided into the subgroups based on their treatment with/without sitagliptin and VitD3. The expression of T-bet, RORγt, BCL6, and FOXP3 was evaluated using real-time PCR. The levels of IFN-γ, IL-6, IL-17, IL-21, TGF-ß, and IL-37 were assessed in PBMC supernatants using ELISA. Results: The production of IFN-γ and IL-17 was increased in untreated (without sitagliptin and VitD3) nephropathic and non-nephropathic T2DM patients compared with healthy controls, whereas FOXP3 expression was decreased. Treatment with sitagliptin alone or in combination with VitD3 reduced the production of IFN-γ in the patients. Production of IL-17 and IL-21 and the expression of RORγt and BCL6 was diminished in patients treated with combined sitagliptin and VitD3, whereas the production of IL-37 and FOXP3 expression were increased in the patients treated with sitagliptin or sitagliptin plus VitD3. Conclusion: These data demonstrate that sitagliptin in combination with VitD3 may accelerate the process of T2DM treatment by exerting synergic anti-inflammatory effects on immune system through upregulation of FOXP3 and IL-37, and downregulation of RORγt and BCL6 as well as IFN-γ, IL-17 and IL-21 production. Combined sitagliptin and VitD3 can be safely utilized to modulate the inflammatory conditions of T2DM.

A review on the effects of extremely low frequency electromagnetic field (ELF-EMF) on cytokines of innate and adaptive immunity.

Extremely low frequency electromagnetic field (ELF-EMF) is produced extensively in modern technologies. Numerous in vitro and in vivo studies have shown that ELF-EMF has both stimulatory and inhibitory effects on the immune system response. This review was conducted on effects of ELF-EMF on cytokines of innate and adaptive immunity. Mechanisms of ELF-EMF, which may modulate immune cell responses, were also studied. Physical and biological parameters of ELF-EMF can interact with each other to create beneficial or harmful effect on the immune cell responses by interfering with the inflammatory or anti-inflammatory cytokines. According to the studies, it is supposed that short-term (2-24 h/d up to a week) exposure of ELF-EMF with strong density may increase innate immune response due to an increase of innate immunity cytokines. Furthermore, long-term (2-24 h/d up to 8 years) exposure to low-density ELF-EMF may cause a decrease in adaptive immune response, especially in Th1 subset.

The effects of extremely low-frequency electromagnetic fields on c-Maf, STAT6, and RORα expressions in spleen and thymus of rat.

The study investigated the effect of extremely low-frequency electromagnetic fields (ELF-EMFs) exposure at different magnetic flux densities on genes expression of transcription factor Maf (c-Maf), signal transducer and activator of transcription 6 (STAT6), and retinoid-related orphan receptor alpha (RORα) in the spleen and thymus of rats. Eighty adult male rats were separated into four ELF-EMFs exposed and were exposed to magnetic flux densities of 1, 100, 500, and 2000 µT at a frequency of 50 Hz for 2 h daily for up to 60 d. All rats were intraperitoneally immunized on d 31, 44, and 58 of exposure. The experimental results showed that the expression levels of c-Maf, STAT6, and RORα in the thymus were not significantly changed at different magnetic flux densities. The expression levels of RORα and c-Maf were significantly downregulated at the densities of 1 and 100 µT, while the expression of STAT6 was only significantly decreased at the density of 100 µT. In conclusion, low magnetic flux densities of ELF-EMFs may reduce the expression levels of c-Maf, STAT6, and RORα genes in the spleen.

Decreased regulatory function of CD4+CD25+CD45RA+ T cells and impaired IL-2 signalling pathway in patients with type 2 diabetes mellitus.

In this study, the frequency and function of CD4+CD25+CD45RA+ regulatory T cells (Treg) and intracellular IL-2 signalling molecules in patients with type 2 diabetes mellitus (T2DM) were investigated. Tregs and responder T cells (Tresp, CD4+CD25- T cells) were sorted and suppression assays were performed using flow cytometry. Phosphorylation of signal transducer and activator of transcription-5 (pSTAT5) were assessed using flow cytometry. Gene expression of FOXP3 was performed with the SYBR green Real Time PCR method. Production of IL-2 from cultured cells was assessed using ELISA. We observed a functional defect of CD4+CD25+CD45RA+ Tregs in T2DM patients with higher proliferation of Tresp cells, in response to anti-CD3 and anti CD28 stimulation in the presence of Tregs in vitro. The results showed that the proliferation of Tresps in the absence of Treg cells was higher in T2DM patients than in healthy controls. Decreased FOXP3 mRNA expression and pSTAT5 were observed within the Tregs of the patients, whereas the level of secreted IL-2 from PBMCs culture was not statically different between T2DM patients and healthy individuals. Changes in intracellular IL-2 pathways and FOXP3 gene expression may contribute to the defect of Tregs in T2DM patients. These findings indicating that the purified CD4+CD25+CD45RA+ Treg cells have reduced functional capacity together with impaired IL-2 pathway in T2DM, and the Tregs could be used for a potential novel therapeutic target.

New data on Dysdera Latreille, 1804 and Harpactea Bristowe, 1939 (Araneae: Dysderidae) of the Caucasus, with new species and records.

In this paper, we provide new taxonomic and faunistic data on the dysderid spider genera Dysdera Latreille, 1804 and Harpactea Bristowe, 1939 based on material collected in the Caucasus region. We identified a total of seventeen species, of which D. atabekia sp. n. (; Goychay and Ismayilli districts, Azerbaijan), H. abasgiana sp. n. (; Republic of Abkhazia, Georgia), and H. dunini sp. n. (; Zagatala district, Azerbaijan) are described as new to science and their distributions are mapped. Furthermore, three new records are provided: D. daghestanica Dunin, 1991 from Krasnodar Krai, D. concinna L. Koch, 1878 from Iran, and D. mazini Dunin, 1991 from Azerbaijan. By examining the type series of Harpactea caucasia (Kulczyski, 1895), we found that at least a part of Dunins records of this species refer to H. abasgiana sp. n., and his figures of this species in fact refer to an undescribed species. Brief notes are provided on the northernmost distribution limits of Dysderidae.

Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus.

OBJECTIVE: The potential immunoregulatory capacity of sitagliptin on interleukin-29 (IL-29) and genes involved in its intracellular pathway were explored in type 2 diabetes mellitus (T2D). MATERIALS AND METHODS: T2D patients treated with six months of sitagliptin (Sita+), patients not treated with sitagliptin (Sita-), and healthy controls (HCs) were included. IL-29 levels in the supernatant of stimulated mononuclear immune cells was determined with ELISA. The mRNA expression levels of IL-29, FOS, JUN, NF-AT2, NF-KB1, STAT1-2, IRF1, IRF3, IRF7, and IRF9 was assessed with real-time qPCR. RESULTS: Increased protein and gene levels of IL-29 were observed in Sita- group compared to HCs (p < 0.001 and p = 0.026), while those levels were diminished in Sita+ group in comparison with Sita- group (p < 0.001 and p = 0.008). Expression of FOS, NF-AT2 and NF-KB1 in Sita- patients was higher than HCs (p = 0.018, p = 0.021, and p = 0.001). A significant decrease in expression of FOS, NF-AT2, and NF-KB1 was found in Sita+ group versus Sita- parients (p = 0.027, p = 0.003, and p = 0.002). In Sita- patients, IL-29 levels were correlated to glucose metabolism parameters including FPG and HbA1c (p < 0.05 for all). CONCLUSION: Sitagliptin administration has a regulatory effect on the aggressive expression of IL-29 and its signaling molecules including FOS, NF-AT2 and NF-KB1 in T2D.

Different Gene Expression Patterns of IL-1 Family Members in Parkinson's Disease: Results from Bayesian Regression Model.

Parkinson's disease, the second most prevalent neurodegenerative disorder lacking a recognized etiology, is influenced by oxidative stress and alterations in inflammatory cytokine levels. This study aimed to investigate the expression levels of Interleukin(IL)1 receptor accessory protein (IL-1RAcP), IL1ß, IL1α, IL33, and IL36 genes in blood cells and serum IL-1ß levels in Parkinson's disease patients compared to healthy controls (HCs).I n this case-control study, 44 Parkinson's disease patients and 44 age- and sex-matched HCs were included. Gene expression levels were assessed using Quantitative Real-time PCR, and serum IL-1ß levels were measured via enzyme-linked immunosorbent assay. Advanced statistical analyses using the Bayesian regression model in R software were employed. Parkinson's disease patients exhibited elevated expression levels of IL-1RAcP and IL1ß genes  but decreased levels of IL1α, IL33, and IL36 compared to HCs. Age-based differences were not significant. Regarding gender, IL33 transcript levels were significantly higher in males, and serum IL-1ß levels were increased in patients. Subgroup analysis by gender indicated alterations in IL1ß and IL-1RAcP expression in both genders, while IL1α, IL33, and IL36 showed reduced expression only in males. Remarkably, only female patients displayed significantly higher serum IL-1ß levels than female HCs. These findings suggest that dysregulation of immune-related factors plays a crucial role in Parkinson's disease.

Exposure of rats to extremely low-frequency electromagnetic fields (ELF-EMF) alters cytokines production.

Investigations indicate a potential link between exposure to extremely low-frequency electromagnetic field (ELF-EMF) and some cancers. Carcinogenesis of ELF-EMF may be mediated by effect on the immune system. During an immune response, naïve T cells differentiate to effector type 1 helper T cells (T(H)1), T(H)2, or T(H)17 subsets according to existence of different cytokines and T(H)1 is important in defense against tumors. Therefore, it will be reasonable to test whether ELF-EMF can change cytokines like interferon gamma (IFN-γ), interleukin-4 (IL-4), IL-6, and IL-12 that regulate T(H)1/T(H)2/T(H)17 balance. Forty adult male rats were randomly separated into ELF-EMF-exposed and sham-exposed control groups. The ELF-EMF group was exposed to a flux density of 100 µT, frequency 50 Hz, 2 h/day for 3 months. The controls were placed in identical chamber without ELF-EMF. The results showed there were no significant differences between the mean mass of rats, thymuses, and spleens in ELF-EMF exposed group compared with controls. Serum IL-12 level was decreased from 418 ± 47 pg/ml in controls to 300 ± 23 pg/ml (p < 0.05) in ELF-EMF-exposed group. Phytohemagglutinin activated of in vitro production of IL-6 by the whole spleen culture (1356 ± 92 pg/ml) and total blood culture (418 ± 40 pg/ml) of ELF-EMF-exposed rats were higher (p < 0.001) comparing with controls (905 ± 74 pg/ml), (182 ± 26 pg/ml), respectively. However, the levels of IFN-γ, IL-4, and IL-6 of serum and IFN-γ, IL-4, and IL-12 in spleen culture and total blood culture of two groups were not significantly different. It seems that ELF-EMF may change T(H)1/T(H)2/T(H)17 balance toward down regulation of T(H)1 and upregulation T(H)17 type responses.

A new species of Chaetopelma Ausserer, 1871 (Araneae, Theraphosidae) from Iran.

New data on the tarantula genus Chaetopelma Ausserer, 1871 are provided. A new species, Ch.persianumsp. nov., is described based on a single female specimen collected in northwestern Iran, which represents the easternmost record of the genus within its entire known range. Additionally, the correct publication date of Ch.olivaceum C.L. Koch, 1842 is discussed, and the known distribution records of all Chaetopelma species are mapped.

Notes on Dysderidae (Arachnida, Araneae) of Armenia and Iran, with new species and records.

New data are provided on dysderid spiders of Armenia and Iran. Dysderahaykanasp. nov. is described based on male specimens collected in Kotayk and Lor provinces, central and northern Armenia. The female of Dysderanakhchivanica Beydizade, Shafaie & Guseinov, 2018 is described for the first time, and the species is newly recorded from Armenia. Furthermore, new distribution data are provided for Harpacteaarmenica Dunin, 1989, including the first record of the species from Iran. Photographs and a distribution map are provided for all three species.

A survey of the spider genus Dysdera Latreille, 1804 (Araneae, Dysderidae) in Iran, with fourteen new species and notes on two fossil genera.

The taxonomy of the Iranian species of the dysderid spider genus Dysdera Latreille, 1804 is revised. Currently, the only species of this genus known from Iran is D.pococki Dunin, 1985, albeit on the basis of a doubtful record. The following 14 species are described as new to science in this paper: D.achaemenessp. nov. (♀; Fars), D.bakhtiarisp. nov. (♂; Chaharmahal & Bakhtiari), D.damavandicasp. nov. (♂; Mazandaran), D.genoensissp. nov. (♂♀; Hormozgan), D.hormuzensissp. nov. (♀; Hormozgan), D.iranicasp. nov. (♂♀; Fars, Hormozgan), D.isfahanicasp. nov. (♂♀; Isfahan), D.mazerunisp. nov. (♀; Mazandaran), D.medessp. nov. (♂; Tehran), D.persicasp. nov. (♂♀; Golestan, Mazandaran), D.sagartiasp. nov. (♂♀; Tehran), D.tapuriasp. nov. (♂♀; Mazandaran), D.verkanasp. nov. (♂; Golestan), and D.xerxesisp. nov. (♂; Bushehr). Distribution records of all species are mapped. Also, the taxonomy of Mistura Petrunkevitch, 1971 and Segistriites Straus, 1967, two fossil genera currently considered in Dysderidae, is discussed and the latter is transferred to Segestriidae.

New data on cave spiders (Arachnida: Araneae) of Iran, with new species and records.

New data on Iranian spiders is provided based on 92 specimens collected from the interiors or surroundings of 27 caves. These specimens belong to 17 species in nine families, of which five species are described as new to science: Tegenaria pallens Zamani & Marusik, sp. n. (; Gakal Cave, Kohgiluyeh & Boyer-Ahmad Province) (Agelenidae); Dysdera elamana Zamani & Marusik, sp. n. (; Barreh Zard Cave, Ilam Province); and Harpactea zagros Zamani & Marusik, sp. n. (; Raad-e Gharbi Cave, Ilam Province) (both Dysderidae); Troglohyphantes megagynus Zamani & Marusik, sp. n. (; Kabootarlan Cave, Ilam Province) (Linyphiidae); and Mesiotelus iranicus Zamani & Marusik, sp. n. (; Mir Melas Cave, Lorestan Province) (Liocranidae). Additionally, two genera, Scotargus Simon, 1913 and Odontodrassus Jzquel, 1965, and three species, Odontodrassus mundulus (O. Pickard-Cambridge, 1872) and Synaphosus syntheticus (Chamberlin, 1924) (both Gnaphosidae), and Scotargus pilosus Simon, 1913 (Linyphiidae), are recorded in Iran for the first time. The newly described and recorded species are accompanied by illustrations.

Immunomodulatory chitosan nanoparticles for Toxoplasma gondii infection: Novel application of chitosan in complex propranolol-hydrochloride as an adjuvant in vaccine delivery.

The study aimed to investigate the immunomodulatory effects of propranolol hydrochloride (PRO) in combination with chitosan nanoparticles (CS NPs) as an adjuvant to develop an effective vaccine against T. gondii. A total of 105 BALB/c mice were randomly divided into seven equal groups including PBS alone, CS NPs, SAG1 (Surface antigen 1), CS-SAG1 NPs, CS-PRO NPs, SAG1-PRO, and CS-SAG1-PRO NPs. The immunostimulatory effect of each adjuvant used for vaccine delivery was evaluated in a mice immunization model. The results showed that the mice immunized with CS-SAG1-PRO NPs exhibited the highest lymphocyte proliferation rate, along with increased secretion of IFN-γ, TNF-α, IL-6, IL-12, IL-17, and IL-23, as well as elevated levels of protective cytokines such as TGF-ß, IL-27, and IL-10. Although, the CS-SAG1-PRO NPs immunized mice showed the highest level of T. gondii specific IgG compared to the other groups, a significant production of IgG2a and IgG1 was observed in the sera of mice immunized with the CS-SAG1-PRO NPs compared to the other group (p <0.001). The higher IgG2a/IgG1 ratio observed in the CS-SAG1-PRO NPs group indicates a bias towards Th1 cell polarization, suggesting the promotion of Th1 cell-mediated immune responses. Considering the combination of the highest lymphocyte proliferation and survival rates, IgG2a/IgG1 ratio, and cytokine levels in the mice immunized with CS-SAG1-PRO NPs, this approach holds promise for immunostimulation and vaccine delivery against T. gondii infection.

A new genus of Textricini Lehtinen, 1967 (Araneae, Agelenidae) from Anatolia.

Türkiye is known to have the highest diversity of the spider family Agelenidae in the Western Palaearctic and the highest diversity of the subfamily Ageleninae globally. The new agelenid genus Anatextrixgen. nov. (Ageleninae, Textricini) and its type species, A.spectabilissp. nov. (♂♀; Mersin and Adana provinces, southern Türkiye), are described. A key to all four genera of Textricini is provided.

An updated and annotated checklist of the spiders (Arachnida: Araneae) of Iraq.

An updated and annotated checklist of the spiders of Iraq, currently comprising 104 species in 75 genera and 29 families is presented, including six endemic and four subendemic species. Twenty-three records are considered misidentifications and therefore omitted from the checklist. Where possible, the misidentified records are attributed to other species based on their distribution and morphology; as a result of this, three species are recorded in Iraq for the first time: Dictis striatipes L. Koch, 1872 (Scytodidae), Hippasa deserticola Simon, 1889 (Lycosidae) and Latrodectus cinctus Blackwall, 1865 (Theridiidae). The history of studies and the geographical distribution of records are reviewed and discussed. The list is dominated by members of the families Gnaphosidae, Lycosidae, and Salticidae, comprising 15.4%, 13.5% and 10.6% of the total number of species, respectively.

Effect of 50-Hz magnetic fields on the expression of activation-induced deaminase, B-cell lymphoma 6 and serum levels of interleukin-6, interleukin-21.

BACKGROUND: Investigations showed different effects of magnetic fields (MFs) on the immune system. During humoral immune responses, genes of activation-induced deaminase (AID) and B-cell lymphoma-6 (Bcl-6) are expressed and interleukin (IL)-6 and IL-21 are produced. These factors play significant roles in class switching, affinity maturation of antibodies and activations of B cells germinal centers (GCs). Therefore, this study investigated the effect of 50-Hz MFs exposure with different densities on these factors. MATERIALS AND METHODS: Eighty rats were divided into four exposures and control groups. The treatment groups were exposed to magnetic flux densities of 1, 100, 500, and 2000 µT (50 Hz, 2 h/d for 60 d). To activation of the immune system, all the animals were immunized with human serum albumin on days 31, 44, and 58 of exposure. Reverse transcription-quantitative polymerase chain reaction was used to assay the expression levels of AID and Bcl-6 genes in the spleen. The serum levels of IL-6 and IL-21 were also detected by enzyme-linked immunosorbent assay at the pre-and post-immunization phases. RESULTS: AID expression was significantly declined at 1µT magnetic flux density, while no change was observed in the expression of Bcl-6. Serum IL-6 was increased only in the 500 µT group at the post-immunization phase. CONCLUSIONS: It seems exposure to 50-Hz MFs at 1 µT density, suppresses AID and may cause a decline in class switching and affinity maturation of Abs. On the other hand, exposure to 500 µT, may activate them. These findings demonstrate the various potential effects of MFs on the humoral immune system.